Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TALAZOPARIB vs TALQUETAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TALAZOPARIB vs TALQUETAMAB: Safety Overview

Metric TALAZOPARIB TALQUETAMAB
Total FAERS Reports 1,477 515
Deaths Reported 278 81
Death Rate 18.8% 15.7%
Hospitalizations 553 224
Average Patient Age 60.1 yrs 65.7 yrs
% Female Patients 55.7% 42.4%
FDA Approval Date Jun 20, 2023 N/A
Manufacturer Pfizer Laboratories Div Pfizer Inc Janssen Biotech, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Discontinued N/A